Lista de obras - Mario Cazzola - Dominio Público Uruguay

A potential role of triple therapy for asthma patients

scientific article published on 01 September 2019

A review of the pharmacokinetics of M3 muscarinic receptor antagonists used for the treatment of asthma

scientific article published on 30 January 2020

A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD.

artículo científico publicado en 2018

ACE2: The Major Cell Entry Receptor for SARS-CoV-2

artículo científico publicado en 2020

Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination

artículo científico publicado en 2020

Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease

artículo científico publicado en 2020

An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?

artículo científico publicado en 2017

Chronic Obstructive Pulmonary Disease and Stroke

scientific article published on 10 May 2018

Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents

artículo científico publicado en 2018

Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how.

artículo científico publicado en 2018

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation

scientific article published on 02 December 2019

Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review

artículo científico publicado en 2020

Emerging antibacterial and antiviral drugs for treating respiratory tract infections

artículo científico publicado en 2018

Emerging muscarinic receptor antagonists for the treatment of asthma

scientific article published on 21 April 2020

Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD

scientific article published on 01 September 2019

Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies

artículo científico publicado en 2020

Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review

scientific article published on 04 April 2020

Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review

artículo científico publicado en 2020

How does race/ethnicity influence pharmacological response to asthma therapies?

artículo científico publicado en 2018

Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.

artículo científico publicado en 2017

Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease

artículo científico publicado en 2019

Investigational treatments in phase I and II clinical trials: a systematic review in chronic obstructive pulmonary disease (COPD)

scientific article published on 13 May 2020

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease

scientific article published on 08 December 2020

Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent

artículo científico publicado en 2020

Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease

artículo científico publicado en 2018

New perspectives on the role of muscarinic antagonists in asthma therapy

scientific article published on 22 April 2020

Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings

scientific article published on 04 September 2020

Pharmacogenetic and pharmacogenomic considerations of asthma treatment.

artículo científico publicado en 2017

Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy

artículo científico publicado en 2020

Pharmacokinetic considerations concerning the use of bronchodilators in the treatment of chronic obstructive pulmonary disease

artículo científico publicado en 2018

Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs

scientific article published on 07 January 2021

Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma

artículo científico publicado en 2017

Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma.

artículo científico publicado en 2017

Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi.

artículo científico publicado en 2017

Pharmacological management of adult patients with acute respiratory distress syndrome

scientific article published on 12 August 2020

Pharmacological treatment and current controversies in COPD

artículo científico publicado en 2019

Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab

scientific article published on 08 March 2018

Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach?

artículo científico publicado en 2018

The 5T approach in asthma: Triple Therapy Targeting Treatable Traits

artículo científico publicado en 2022

The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians

artículo científico publicado en 2020

The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils

artículo científico publicado en 2016

The role of triple therapy in the management of COPD

artículo científico publicado en 2020

The safety of dual bronchodilation on cardiovascular serious adverse events in COPD

artículo científico publicado en 2018

Lista de obras de Mario Cazzola

A potential role of triple therapy for asthma patients

A review of the pharmacokinetics of M3 muscarinic receptor antagonists used for the treatment of asthma

A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD.

ACE2: The Major Cell Entry Receptor for SARS-CoV-2

Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination

Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease

An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?

Chronic Obstructive Pulmonary Disease and Stroke

Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents

Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how.

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation

Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review

Emerging antibacterial and antiviral drugs for treating respiratory tract infections

Emerging muscarinic receptor antagonists for the treatment of asthma

Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD

Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies

Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review

Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review

How does race/ethnicity influence pharmacological response to asthma therapies?

Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.

Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease

Investigational treatments in phase I and II clinical trials: a systematic review in chronic obstructive pulmonary disease (COPD)

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease

Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent

Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease

New perspectives on the role of muscarinic antagonists in asthma therapy

Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings

Pharmacogenetic and pharmacogenomic considerations of asthma treatment.

Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy

Pharmacokinetic considerations concerning the use of bronchodilators in the treatment of chronic obstructive pulmonary disease

Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs

Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma

Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma.

Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi.

Pharmacological management of adult patients with acute respiratory distress syndrome

Pharmacological treatment and current controversies in COPD

Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab

Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach?

The 5T approach in asthma: Triple Therapy Targeting Treatable Traits

The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians

The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils

The role of triple therapy in the management of COPD

The safety of dual bronchodilation on cardiovascular serious adverse events in COPD